UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 275

Sortiert nach

Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies

Drug discovery today, 2015-09, Vol.20 (9), p.1127-1134

2015

Link zum Volltext

Verfügbarkeit prüfen

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis

Frontiers in oncology, 2023-05, Vol.13, p.1176173

2023

Link zum Volltext

Verfügbarkeit prüfen

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

Oncotarget, 2015-06, Vol.6 (18), p.15772-15787

2015

Link zum Volltext

Verfügbarkeit prüfen

642 TGFβ-based immune modulatory vaccines

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A735-A735

Andersen, Mads H

2023

Link zum Volltext

Verfügbarkeit prüfen

ABO blood types and sepsis mortality

Annals of intensive care, 2021-04, Vol.11 (1), p.61-61, Article 61

2021

Link zum Volltext

Verfügbarkeit prüfen

Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model

Critical care and resuscitation, 2018-03, Vol.20 (1), p.54-60

2018

Link zum Volltext

Verfügbarkeit prüfen

Profound endothelial damage predicts impending organ failure and death in sepsis

Seminars in thrombosis and hemostasis, 2015-02, Vol.41 (1), p.16

2015

Link zum Volltext

Verfügbarkeit prüfen

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

Science translational medicine, 2022-06, Vol.14 (649), p.eaba4380

2022

Link zum Volltext

Verfügbarkeit prüfen

Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

Vaccine, 2017-10, Vol.35 (42), p.5629-5636

2017

Link zum Volltext

Verfügbarkeit prüfen

Postfilter ionized calcium measurements in citrate anticoagulation for continuous renal replacement therapy: How often should Ca2+-membrane in blood gas analyser ABL800 be replaced?

Annals of clinical biochemistry, 2018-09, Vol.55 (5), p.620-621

2018

Link zum Volltext

Verfügbarkeit prüfen

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

Cancer Immunology, Immunotherapy, 2012-11, Vol.61 (11), p.2091-2103

2012

Link zum Volltext

Verfügbarkeit prüfen

Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion

Journal of investigative dermatology, 2013-02, Vol.133 (2), p.545-552

2013

Link zum Volltext

Verfügbarkeit prüfen

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

Cancer Immunology, Immunotherapy, 2006-10, Vol.55 (10), p.1294-1298

2006

Link zum Volltext

Verfügbarkeit prüfen

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

Blood cancer journal (New York), 2019-01, Vol.9 (2), p.8-8, Article 8

2019

Link zum Volltext

Verfügbarkeit prüfen

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Leukemia & lymphoma, 2019-11, Vol.60 (13), p.3296-3299

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

European journal of immunology, 2009-05, Vol.39 (5), p.1419-1424

2009

Link zum Volltext

Verfügbarkeit prüfen

1335 Arginase-1 vaccine promotes T cell immunity against arginase-1+ cells, controls tumor growth via immune modulation of tumor microenvironment

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1486-A1486

2023

Link zum Volltext

Verfügbarkeit prüfen

918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A1021-A1021

2023

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

Journal of immunotherapy, 2008-10, Vol.31 (8), p.771-780

2008

Link zum Volltext

Verfügbarkeit prüfen

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

Cytotherapy (Oxford, England), 2010-10, Vol.12 (6), p.721-734

2010

Link zum Volltext

Verfügbarkeit prüfen

Establishing the pig as a large animal model for vaccine development against human cancer

Frontiers in genetics, 2015, Vol.6, p.286-286

2015

Link zum Volltext

Verfügbarkeit prüfen

Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue

Cancer Immunology, Immunotherapy, 2008, Vol.57 (1), p.85-95

2008

Link zum Volltext

Verfügbarkeit prüfen

The Procalcitonin And Survival Study (PASS) - a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker Procalcitonin and pro-active diagnostic and therapeutic responses to abnormal Procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients

BMC infectious diseases, 2008-07, Vol.8 (1), p.91-91

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 275

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(254)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Reorienting the immune system in the treatment of cancer by using anti-PD-1 and anti-PD-L1 antibodies

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis

Oncogenic cancer/testis antigens: prime candidates for immunotherapy

642 TGFβ-based immune modulatory vaccines

ABO blood types and sepsis mortality

Predicting recovery from acute kidney injury in critically ill patients: development and validation of a prediction model

Procalcitonin-guided interventions against infections to increase early appropriate antibiotics and improve survival in the intensive care unit: A randomized trial

Profound endothelial damage predicts impending organ failure and death in sepsis

Calreticulin mutant myeloproliferative neoplasms induce MHC-I skewing, which can be overcome by an optimized peptide cancer vaccine

Low antigen dose formulated in CAF09 adjuvant Favours a cytotoxic T-cell response following intraperitoneal immunization in Göttingen minipigs

Postfilter ionized calcium measurements in citrate anticoagulation for continuous renal replacement therapy: How often should Ca2+-membrane in blood gas analyser ABL800 be replaced?

Invasive Candida Infections and the Harm From Antibacterial Drugs in Critically Ill Patients: Data From a Randomized, Controlled Trial to Determine the Role of Ciprofloxacin, Piperacillin-Tazobactam, Meropenem, and Cefuroxime

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

Progression of JAK2-mutant polycythemia vera to CALR-mutant myelofibrosis severely impacts on disease phenotype and response to therapy

Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes

1335 Arginase-1 vaccine promotes T cell immunity against arginase-1+ cells, controls tumor growth via immune modulation of tumor microenvironment

918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

Therapeutic dendritic cell vaccination of patients with metastatic renal cell carcinoma: a clinical phase 1/2 trial

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

Establishing the pig as a large animal model for vaccine development against human cancer

Immunological tumor destruction in a murine melanoma model by targeted LTα independent of secondary lymphoid tissue

Suchergebnisse filtern